FunderPro is proud to unveil its latest innovation in the prop trading industry – the New “FunderPro Swing Accounts.” This pioneering program is set to redefine proprietary trading, offering unparalleled flexibility to traders worldwide.

Unmatched Flexibility with FunderPro Swing Accounts
Designed for traders who seek the freedom to hold positions over weekends and during major news events, the FunderPro Swing Accounts provide a level of adaptability that is rare in the prop trading sector. This program is meticulously tailored to accommodate the modern trader’s dynamic needs, offering a fresh perspective on trading strategies.
Features of FunderPro Swing Accounts
Breaking away from the conventional prop trading model, FunderPro Swing Accounts come with several distinctive features:
- Elimination of the minimum trading days requirement, allowing traders to advance based on profit achievements alone.
- Removal of the consistency rule, encouraging traders to explore diverse trading strategies that suit their individual style.
- Continuation of daily payouts, ensuring traders receive the financial rewards of their efforts promptly.
This strategic shift towards a more flexible and results-oriented approach marks a significant evolution in proprietary trading, allowing traders to navigate the markets with greater confidence and freedom.
FunderPro: A New Era in Proprietary Trading
FunderPro’s commitment to adapting to the needs of the trading community is evident in the launch of the Swing Accounts. By offering a program that aligns with the versatile and varied approaches of modern traders, FunderPro is facilitating a new era of trading success.
About FunderPro
FunderPro is a trailblazing proprietary trading firm dedicated to revolutionizing the trading experience. By providing traders the opportunity to manage up to $200,000 with an 80% profit split, FunderPro is setting new standards in risk management and profit potential. Traders are empowered to trade a broad spectrum of instruments, opening up myriad paths to success.